logo

For the Inventor, By the Inventor

El Cerrito, CA, United States of America

Manfred Gossen

This inventor holds 20 USPTO granted patents and 2 EPO patents, primarily in Gene Regulation Technology. Top assignees: Basf Aktiengesellschaft, Knoll Aktiengesellschaft, Abbott Gmbh & Co Kg. Active years: 1995-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manfred Gossen. Retrieved from https://idiyas.com/inventor/manfred-gossen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20

% Patents Active = 95.0


Average Co-Inventor Count = 2.5

ph-index = 17

Forward Citations = 949(Granted Patents)


Location History:

  • El Cerrito, DE (1996)
  • Berkeley, CA (US) (1997)
  • Heidelberg, DE (1995 - 1999)
  • El Cerrito, CA (US) (1998 - 2005)

Company Filing History:

goldMedal12 out of 10,816 
 
Basf Aktiengesellschaft
 patents
silverMedal6 out of 84 
 
Knoll Aktiengesellschaft
 patents
bronzeMedal1 out of 140 
 
Abbott Gmbh & Co Kg
 patents
4. 1 out of 1 
 
Basf Bioresearch Corporation
 patent
5. 1 out of 1 
 
Knoll Aktiengelellschaft
 patent
6. 1 out of 1 
 
Knoll Aktiengellschaft
 patent
7. 1 out of 1 
 
Knoll Aktiengesellchaft
 patent
8. 1 out of 3 
 
Tet Systems Holding Gmbh & Co. Kg
 patents
9. 1 out of 6 
 
University of Heidelberg
 patents
10. 6 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2005

Loading Chart...
Loading Chart...
Areas of Expertise:
Gene Expression
Transcriptional Activators
Tetracycline-Regulated Systems
Transgenic Organisms
Gene Regulation
Transcriptional Inhibitors
Eucaryotic Cells
Fusion Proteins
Transactivation Potential
Regulatory Systems
Controlled Expression
Tetracycline-Inducible
20 patents (USPTO):Explore Patents
1. 6914124 - Tetracycline-regulated transcriptional activator fusion proteins (2005-07-05),
2. 6783756 - Methods for regulating gene expression (2004-08-31),
3. 6271348 - Tetracycline-inducible transcriptional inhibitor fusion proteins (2001-08-07),
4. 6271341 - Transcriptional activators with graded transactivation potential (2001-08-07),
5. 6252136 - Transgenic organisms having tetracycline-regulated transcriptional regulatory systems (2001-06-26),
6. 6242667 - Transgenic organisms having tetracycline-regulated transcriptional regulatory systems (2001-06-05),
7. 6136954 - Tetracycline-inducible transcriptional activator fusion proteins (2000-10-24),
8. 6087166 - Transcriptional activators with graded transactivation potential (2000-07-11),
9. 6004941 - Methods for regulating gene expression (1999-12-21),
10. 5922927 - Methods for producing tetracycline-regulated transgenic mice (1999-07-13),
11. 5912411 - Mice transgenic for a tetracycline-inducible transcriptional activator (1999-06-15),
12. 5888981 - Methods for regulating gene expression (1999-03-30),
13. 5866755 - Animals transgenic for a tetracycline-regulated transcriptional inhibitor (1999-02-02),
14. 5859310 - Mice transgenic for a tetracycline-controlled transcriptional activator (1999-01-12),
15. 5814618 - Methods for regulating gene expression (1998-09-29),

Certainly! Here is the article about the inventor Manfred Gossen:

Title: Manfred Gossen - Pioneering Innovations in Genetic Regulation

Introduction:

Manfred Gossen, a distinguished innovator based in El Cerrito, CA, has made significant contributions to the field of genetic regulation through his groundbreaking inventions and patents.

Latest Patents:

Gossen's latest patents include the development of "Tetracycline-regulated transcriptional activator fusion proteins," a method for precisely regulating gene expression in cells using tetracycline-controllable transactivators. This innovative approach offers new possibilities for controlling gene expression in various biological contexts.

Career Highlights:

With an impressive portfolio of 20 patents, Gossen has established himself as a leading figure in the field of genetic engineering. His work not only showcases his technical prowess but also his deep understanding of cellular mechanisms and regulatory pathways.

Collaborations:

Throughout his career, Gossen has collaborated with notable figures in the industry, including Hermann Bujard and Jochen G Salfeld. These partnerships have led to the development of cutting-edge technologies and have paved the way for further advancements in genetic research.

Conclusion:

In conclusion, Manfred Gossen's relentless pursuit of innovation and his pioneering work in genetic regulation have positioned him as a trailblazer in the field. His patents and inventions continue to inspire future generations of researchers and scientists, driving progress in the exciting realm of genetic engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…